CT-2584 is an angiogenesis inhibitor and lysophosphatidic acid acyltransferase inhibitor with potential anticancer applications. It disrupts phospholipid signaling by inhibiting CTP:choline-phosphate cytidylyltransferase (CT), redirecting phospholipid biosynthesis from phosphatidylcholine (PC) to phosphatidylinositol (PI). This unique modulation of phospholipid metabolism contributes to its cytotoxic effects on cancer cells. Reagent grade, for research purpose.
Usually ships within 24 hours.